HJBR May/Jun 2026

HEALTHCARE JOURNAL OF BATON ROUGE I  MAY / JUN 2026 19 Over the past few decades, technology has fundamentally reshaped entire industries — not by dismantling them, but by redefining the experience of the consumer. In sector after sector, digital innovation has delivered more intuitive interfaces, higher-quality interactions, expanded choice, and a level of convenience that meets people where they are, rather than forcing them to navigate rigid institutional structures. Consider the transformation of the banking industry. What was once an experience defined by limited hours, physical branches, and trans- actional friction has evolved into a seamless, on-demand service layer — instant transfers, remote deposits, real-time insights — acces- sible from anywhere. Importantly, this evolu- tion did not destroy banking; it strengthened it by aligning the system more closely with the needs of its users. Yet, this progress has not been without trade-offs. The same forces that enabled convenience and scale also acceler- ated consolidation, giving rise to large, mono- lithic institutions and, in many communities, the quiet disappearance of the local bank where relationships were personal, service was famil- iar, and someone still knew your name. The challenge is leveraging technology at scale to improve efficiency and effectiveness, while concomitantly preserving humanism, or at least finding the right balance between hu- man and digital connection. Healthcare’s Digital Transformation: Real Progress, Meaningful Gains, but Persistent Failures A similar transformation has unfolded in healthcare over the past few decades, and to be clear, meaningful progress has been made. The rise of the electronic patient portal has fundamentally altered the patient–provider in- terface, allowing individuals to message their clinicians directly, review test results in real time, and access detailed after-visit summaries that reinforce care plans and improve under- standing. Educational materials that were once inconsistently delivered are now standardized and readily available, empowering patients to engage more actively in their own care. These foundational advances have also enabled en- tirely new modes of care delivery, such as eVis- its, virtual visits, and remote patient monitor- ing, which extend the reach of the healthcare system beyond the walls of the clinic and into patients’ daily lives. Even seemingly mundane improvements, such as the transition away from illegible handwritten notes to structured, digi- tal documentation, have enhanced continuity, safety, and the ability to synthesize a patient’s longitudinal story. Embedded clinical decision support tools now provide real-time safeguards — flagging potential drug interactions, alerting clinicians to documented allergies, and high- lighting medication-specific risks — adding an additional layer of protection that was previ- ously unreliable or absent. By many measures, healthcare has embraced technology in ways that mirror other industries’ efforts to improve access, communication, and user experience. And yet, despite these advances, the fun- damental problems in healthcare remain stubbornly intact — and in many cases, more pronounced. As I have argued before in this magazine, the system often seems to gener- ate more friction than relief. Costs remain exorbitant and continue to rise at a pace that outstrips wages and household stability, forc- ing patients into devastating trade-offs, such as choosing between paying for medications or paying for food, between keeping the lights on or pursuing life-saving care. Beneath this financial strain lies profound and often unjustifiable variation, not only in what care costs, but in the quality delivered; two pa- tients with the same condition can experience vastly different outcomes depending on where they enter the system. And while technology has improved certain aspects of the patient experience, breakdowns in communication, fragmented care, and administrative burden still leave many patients feeling unseen and unheard. Access remains another persistent fault line: long wait times, specialist shortages, and geo- graphic disparities delay care when time mat- ters most. Even when breakthrough therapies exist — drugs that can slow disease progres- sion or extend life — they, too, often remain out of reach, constrained by cost-sharing struc-